EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Assays for Measuring the Cell Permeability of Proteolysis-Targeting Chimeras (PROTACs): Performance, Correlations, Applicability and Recommendations

Christina Brenner, Yunhai Cui iD, Denis Schmidt iD, Johannes Kirchmair iD, Lu Tan, Nina Braun iD

Molecular Pharmaceutics · 2026

DOI: 10.1021/acs.molpharmaceut.5c01908 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Christina Brenner und 5 weiteren Autor:innen. Beteiligte Einrichtung: Drug Discovery Sciences, Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer Gasse 5-11, Vienna A-1121, Austria. Hauptthemen laut MEDLINE: Cell Membrane Permeability. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bundesministerium f??r Arbeit und Wirtschaft, ??sterreichische Forschungsf??rderungsgesellschaft, Christian Doppler Forschungsgesellschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Most Proteolysis-Targeting Chimeras (PROTACs) are beyond-Rule-of-Five compounds, and optimizing their ability to cross cell membranes is a central topic in PROTAC therapeutic research. In this study, we systematically investigate the performance and assay correlations of PROTAC cell permeability assays and the chemical space in which these assays provide reliable results. Our work builds on a comprehensive data set of 3271 PROTACs spanning diverse chemical and target spaces, providing unprecedented coverage of PROTAC cell permeability data. These compounds were measured in up to three different types of assays: the NanoBRET E3 ligase target engagement assay, the Caco-2 assay, and a P-glycoprotein (P-gp) efflux liability assay. We find a strong correlation between readouts from the NanoBRET E3 ligase target engagement assay (availability shift) and those from the Caco-2 assay (apparent intrinsic permeability, basolateral-to-apical permeability, and efflux ratio), while P-gp liability derived from the P-gp assay cannot easily be translated to the Caco-2 efflux ratio. In the process, we also investigate the impact of physicochemical properties included in the Rule-of-Five on the applicability of the assays. Based on these findings, we derive guidelines and data-driven recommendations for the use of cell permeability assays in PROTAC optimization. While this study focuses on PROTACs, some of the observations may be relevant to other modalities with beyond-Rule-of-Five physicochemical properties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell Membrane PermeabilityHumansProteolysis Targeting ChimeraCaco-2 CellsProteolysisATP Binding Cassette Transporter, Subfamily B, Member 1Ubiquitin-Protein Ligases

Stichwörter der Autor:innen

NanoBRETP-gpPROTACsassay correlationscaco-2cellular permeability

Substanzen

Proteolysis Targeting ChimeraATP Binding Cassette Transporter, Subfamily B, Member 1Ubiquitin-Protein Ligases

Autor:innen und Institutionen

  • Drug Discovery Sciences, Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer Gasse 5-11, Vienna A-1121, Austria.
  • Department of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2, Vienna 1090, Austria.
  • Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, Biberach an der Riß 88400, Germany.
  • Medicinal Chemistry, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, Biberach an der Riß 88400, Germany.
  • Christian Doppler Laboratory for Molecular Informatics in the Biosciences, Department for Pharmaceutical Sciences, University of Vienna, Vienna 1090, Austria.

ORCID-Profile: Yunhai Cui, Denis Schmidt, Johannes Kirchmair, Nina Braun

Förderung

  • Bundesministerium f??r Arbeit und Wirtschaft
  • ??sterreichische Forschungsf??rderungsgesellschaft
  • Christian Doppler Forschungsgesellschaft
  • ??sterreichische Nationalstiftung f??r Forschung, Technologie und Entwicklung

Zitieren

APA

Brenner, C., Cui, Y., Schmidt, D., Kirchmair, J., Tan, L., & Braun, N. (2026). Assays for Measuring the Cell Permeability of Proteolysis-Targeting Chimeras (PROTACs): Performance, Correlations, Applicability and Recommendations. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01908

Vancouver

Brenner C, Cui Y, Schmidt D, Kirchmair J, Tan L, Braun N. Assays for Measuring the Cell Permeability of Proteolysis-Targeting Chimeras (PROTACs): Performance, Correlations, Applicability and Recommendations. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.5c01908

BibTeX
@article{Brenner2026,
  author = {Brenner, Christina and Cui, Yunhai and Schmidt, Denis and Kirchmair, Johannes and Tan, Lu and Braun, Nina},
  title = {Assays for Measuring the Cell Permeability of Proteolysis-Targeting Chimeras (PROTACs): Performance, Correlations, Applicability and Recommendations},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  doi = {10.1021/acs.molpharmaceut.5c01908}
}
Kostenlos starten →